ATE543806T1 - 5-aryl-4-(5-substituiertes 2,4-dihydroxyphenyl)-1,2,3-thiadiazole als inhibitoren von hsp90- chaperon und die zwischenprodukte für deren herstellung - Google Patents

5-aryl-4-(5-substituiertes 2,4-dihydroxyphenyl)-1,2,3-thiadiazole als inhibitoren von hsp90- chaperon und die zwischenprodukte für deren herstellung

Info

Publication number
ATE543806T1
ATE543806T1 AT08766671T AT08766671T ATE543806T1 AT E543806 T1 ATE543806 T1 AT E543806T1 AT 08766671 T AT08766671 T AT 08766671T AT 08766671 T AT08766671 T AT 08766671T AT E543806 T1 ATE543806 T1 AT E543806T1
Authority
AT
Austria
Prior art keywords
thiadiazoles
dihydroxyphenyl
aryl
substituted
inhibitors
Prior art date
Application number
AT08766671T
Other languages
English (en)
Inventor
Daumantas Matulis
Inga Cikotiene
Egidijus Kazlauskas
Jurgita Matuliene
Original Assignee
Biotechnologijos Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnologijos Inst filed Critical Biotechnologijos Inst
Application granted granted Critical
Publication of ATE543806T1 publication Critical patent/ATE543806T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT08766671T 2008-04-30 2008-06-18 5-aryl-4-(5-substituiertes 2,4-dihydroxyphenyl)-1,2,3-thiadiazole als inhibitoren von hsp90- chaperon und die zwischenprodukte für deren herstellung ATE543806T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LT2008035A LT5623B (lt) 2008-04-30 2008-04-30 5-aril-4-(5-pakeistieji 2,4-dihidroksifenil)-1,2,3-tiadiazolai kaip hsp90 šaperono slopikliai ir tarpiniai junginiai jiems gauti
PCT/LT2008/000003 WO2009134110A1 (en) 2008-04-30 2008-06-18 5-aryl-4-(5-substituted 2,4-dihydroxyphenyl)-1,2,3-thiadiazoles as inhibitors of hsp90 chaperone and the intermediates for production thereof

Publications (1)

Publication Number Publication Date
ATE543806T1 true ATE543806T1 (de) 2012-02-15

Family

ID=39682765

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08766671T ATE543806T1 (de) 2008-04-30 2008-06-18 5-aryl-4-(5-substituiertes 2,4-dihydroxyphenyl)-1,2,3-thiadiazole als inhibitoren von hsp90- chaperon und die zwischenprodukte für deren herstellung

Country Status (5)

Country Link
US (1) US8314132B2 (de)
EP (1) EP2268626B1 (de)
AT (1) ATE543806T1 (de)
LT (1) LT5623B (de)
WO (1) WO2009134110A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME02144B (me) 2010-12-20 2015-10-20 Sigma Tau Res Switzerland Sa Jedinjenja aril triazola sa antitumorskom aktivnošću

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2559689B1 (fr) 1984-02-22 1987-05-15 Siderurgie Fse Inst Rech Laminoir du type planetaire universel pour produits longs
NZ331062A (en) 1996-10-25 2000-05-26 Kyowa Hakko Kogyo Company Ltd Radicicol derivatives or pharmacologically acceptable salts which show tyrosine kinase inhibition activity and have antitumor effects
US7439359B2 (en) 2000-11-02 2008-10-21 Sloan-Kettering Institute For Cancer Research Small molecule compositions for binding to hsp90
EP1440072A4 (de) 2001-10-30 2005-02-02 Conforma Therapeutic Corp Purinanaloga mit hsp90-inhibierender wirkung
GB0228417D0 (en) 2002-12-05 2003-01-08 Cancer Rec Tech Ltd Pyrazole compounds
KR101166749B1 (ko) * 2003-02-11 2012-07-27 베르날리스(캠브리지)리미티드 열쇼크 단백질 저해제로서의 이소옥사졸 화합물
GB0309637D0 (en) 2003-04-28 2003-06-04 Cancer Rec Tech Ltd Pyrazole compounds
GB0315111D0 (en) 2003-06-27 2003-07-30 Cancer Rec Tech Ltd Substituted 5-membered ring compounds and their use
NZ546611A (en) 2003-09-18 2010-02-26 Conforma Therapeutics Corp Novel heterocyclic compounds as HSP90-inhibitors
JP2005225787A (ja) 2004-02-12 2005-08-25 Nippon Kayaku Co Ltd Hsp90阻害剤
DE102004039280A1 (de) * 2004-08-13 2006-02-23 Merck Patent Gmbh 1,5-Diphenyl-pyrazole
FR2880540B1 (fr) 2005-01-13 2008-07-11 Aventis Pharma Sa Utilisation de derives de la purine comme inhibiteurs de la proteine hsp90
BRPI0609509A2 (pt) 2005-03-30 2010-04-13 Conforma Therapeutics Corp composto ou um polimorfo, solvato, tautÈmero, enanciÈmero, pró-droga ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso do composto, polimorfo, solvato, tautÈmero, enanciÈmero, pró-droga ou sal farmaceuticamente aceitável
CN101193862B (zh) 2005-04-13 2013-08-21 阿斯特克斯治疗有限公司 羟基苯甲酰胺衍生物和其作为hsp90抑制剂的用途
US20070027150A1 (en) 2005-04-14 2007-02-01 Bellamacina Cornelia R 2-Amino-quinazolin-5-ones
JP2006306755A (ja) 2005-04-27 2006-11-09 Nippon Kayaku Co Ltd 新規なピラゾール誘導体とそれを有効成分とするhsp90阻害剤
WO2007021966A1 (en) 2005-08-12 2007-02-22 Synta Pharmaceuticals Corp. Pyrazole compounds that modulate hsp90 activity
CA2618628C (en) 2005-08-18 2014-11-18 Synta Pharmaceuticals Corp. Triazole compounds that modulate hsp90 activity
DE102006023337A1 (de) * 2006-05-18 2007-11-22 Merck Patent Gmbh Triazolderivate II
TW200806637A (en) 2006-05-25 2008-02-01 Synta Pharmaceuticals Corp Synthesis of triazole compounds that modulate HSP90 activity
CA2820957A1 (en) 2006-05-26 2007-12-06 Laboratory Corporation Of America Holdings Liquid chromatography with tandem mass spectrometry of estrone, estradiol and free thyroxine
CN1865252A (zh) * 2006-06-19 2006-11-22 中国科学院上海药物研究所 4,5-二取代苯基-1,2,3-噻二唑类衍生物,及其制备方法和用途
CA2659425C (en) 2006-08-17 2017-06-20 Synta Pharmaceuticals Corp. Triazole compounds that modulate hsp90 activity

Also Published As

Publication number Publication date
EP2268626B1 (de) 2012-02-01
WO2009134110A1 (en) 2009-11-05
EP2268626A1 (de) 2011-01-05
US20110046387A1 (en) 2011-02-24
US8314132B2 (en) 2012-11-20
LT2008035A (en) 2009-11-25
LT5623B (lt) 2010-01-25

Similar Documents

Publication Publication Date Title
TW200728305A (en) Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease
UA97834C2 (ru) Производные сульфониламида для лечения анормального роста клеток
IN2012DN01233A (de)
EA200901133A1 (ru) Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
ATE482210T1 (de) Oxadiazolderivate als s1p1-rezeptor-agonisten
NI200700064A (es) Nuevas composiciones farmacéuticas que comprenden ácido 4-(4-(3-(4-cloro-3- trifluorometil-fenil)- ureido)-3-fluoro-fenoxi)-piridin-2-carboxílico para el tratamiento de trastornos hiperproliferativos.
EA200701799A1 (ru) Транс-каротиноиды, синтез указанных каротиноидов, получение композиций и их применение
ATE538651T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
MX2013008478A (es) 1, 4 riazepinas/sulfonas como inhibidores de beta secretasa 1 (base1) y/o beta secretasa 2 (bace2).
SA522431498B1 (ar) مشتقات 3، 6-داي أمينو-بيريدازين-3-يل، تركيبات صيدلية تحتوي عليها واستخدامها في صورة عوامل مساعدة على تلاشي الخلايا
ATE487720T1 (de) 5,6,7,8-tetrahydropteridin-derivate als hsp90- hemmer
MX2013008213A (es) N-[3-(5-amino-3,3a,7,7a-tetrahidro-1h-2,4-dioxa-6-aza-inden-7-il) -fenil]-amidas como inhibidores de beta-secretasa 1 (bace1) y/o beta-secretasa 2 (bace2).
BRPI0920355B8 (pt) composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina
IL206514A (en) History of triazole oxadiazole, their preparation and their pharmaceutical preparations
UA107349C2 (en) Imidazolidine-2,4-dione derivatives, and use thereof as a cancer drug
DE602004030017D1 (de) Heterocyclische verbindungen als nützliche malonyl-coa decarboxylase-hemmer
TW200716568A (en) 1H-quinazoline-2,4-diones
ATE524486T1 (de) Lys-thr-dipeptide und deren verwendung
MX2011013130A (es) Nuevos compuestos de bencensulfonamida, metodo para sintetizarlos y su utilizacion en medicina asi como tambien en cosmeticos.
JOP20240127A1 (ar) مركبات ثنائي آزا سبيرو بها استبدال بكربونيل واستخدامها
TW200745122A (en) New compounds I
EP1817312A4 (de) Makrozyklische aminiopyridyl-beta-sekretase-hemmer zur behandlung von morbus alzheimer
ATE517900T1 (de) Heptarylen-und octarylentetracarbonsäurediimide und deren herstellung
MA32062B1 (fr) Sels de triazolium comme inhibiteurs de par1, leur production et leur utilisation comme médicaments